ArticleFrontiers in endocrinology2026

γδ T-cell interferon-γ production reflects metabolic improvement during SGLT2 inhibitor-based therapy in type 2 diabetes.

Marija Troskot Cuculić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.